RankAlpha logo
Back to Rankings

MEDP

MedpaceD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
MEDP vs peer average
29/100
MEDP vs. peer average (D vs. C)
Grade spread
A 1 · B 5 · C 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

IQV is the first available peer comparator.

Direct CRO peer explicitly named by Medpace as a major competitor in its 2025 10-K competition section, making it a more relevant operating comp than broad biotech issuers [#10-K-2026-02-10].

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerIQVIQVIA
MEDP
Medpace
IQV
IQVIA
Grade
D
A
Momentum
75
90
Value
62
65
Sentiment
42
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive

Grade position vs IQV

MEDP / IQV
Grade Position
Below peers
MEDP vs. peer average (D vs. C)
29/100
Momentum
75
IQV
Value
62
IQV
Sentiment
42
IQV

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MEDP
1
IQV
IQV
A
100/100
-3
2
ICLR
ICLR
F
20/100
+1
3
FTRE
FTRE
B
80/100
-2
4
JAZZ
Jazz Pharmaceuticals Public Ltd Co Common
B
80/100
-2
5
NBIX
Neurocrine Biosciences Inc Common
B
80/100
-2
IQV is the first peer returned for this comparison set.